Stockholder Sues To Block Pfizer's $6.7B Arena Pharma Buy
An Arena Pharmaceuticals stockholder is challenging Pfizer's bid to buy the company for $6.7 billion, telling a New York federal court that a securities filing omitted important information....To view the full article, register now.
Already a subscriber? Click here to view full article